Target intelligence / Profile preview

Regulator of microtubule dynamics protein 2 (RMDN2)

Target
RMDN2
Molecular classification
Other
01

Overview

RMDN2 (Regulator of microtubule dynamics protein 2) is a protein encoded by the human RMDN2 gene and is characterized by multiple coiled-coil domains that enable microtubule binding and regulation of microtubule dynamics during cell division[1][3][4][6][8][9]. The protein is found in the cytosol during interphase and relocalizes to spindle microtubules and spindle poles during mitosis[9]. It is also detected in the Golgi apparatus and other cytoplasmic locations[6][8]. RMDN2 is broadly expressed in human tissues, with notable expression in multiple brain regions, including the temporal lobe[7][2]. Though not considered an established drug target, recent genome-wide association studies have linked genetic variation near RMDN2 to increased tau deposition in Alzheimer’s disease, and its expression is downregulated in Alzheimer’s brain tissue, suggesting a potential, yet not fully defined, role in neurodegenerative disease etiology[2]. There are currently no known drugs that directly target this protein, nor defined mechanisms of action or specific safety concerns reported.

Other names
FAM82AFAM82A1BLOCK18UNQ9371/PRO34163RMD-2hRMD-2FLJ32954RMD2Protein FAM82A1PRO34163PYST9371RMD4family with sequence similarity 82 member Afamily with sequence similarity 82 member A1microtubule-associated protein
02

Biological functions

Microtubule bindingRegulation of microtubule dynamicsMitotic spindle organizationCell divisionIntracellular transportLocalizes to Golgi apparatus, cytosol, spindle microtubules, and spindle poles[6][8][9]
03

Disease associations

Neurodegenerative disease (notably Alzheimer's disease, based on GWAS loci association and expression changes in Alzheimer’s disease brain, especially in the parahippocampal gyrus[2])
04

Biomarkers

Association of genetic variant near RMDN2 (e.g., rs2113389) with tau deposition and expression changes; potential use as a marker for tau pathology risk in Alzheimer’s disease[2]

Beyond the preview

Go deeper on Regulator of microtubule dynamics protein 2 (RMDN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regulator of microtubule dynamics protein 2 (RMDN2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call